Valuation: Sopharma AD

Market Cap 1.94B 1.17B 992M 924M 869M 1.61B 110B 1.64B 10.99B 4.26B 52.88B 4.38B 4.28B 184B P/E 2024
12.3x
P/E 2025 7.16x
Enterprise Value 2.48B 1.49B 1.27B 1.18B 1.11B 2.06B 141B 2.09B 14.05B 5.45B 67.64B 5.6B 5.48B 235B EV / Sales 2024
0.66x
EV / Sales 2025 0.76x
Free-Float
31.06%
Yield 2024
2.68%
Yield 2025 -
1 week-0.52%
Current month+2.66%
1 month+2.66%
3 months+8.73%
6 months+35.48%
Current year+35.48%
1 week 1.9
Extreme 1.895
1.93
1 month 1.85
Extreme 1.85
1.95
Current year 1.41
Extreme 1.41
2
1 year 1.17
Extreme 1.1741
2
3 years 0.89
Extreme 0.8858
2
5 years 0.57
Extreme 0.5729
2
10 years 0.41
Extreme 0.4087
2
Manager TitleAgeSince
Chief Executive Officer 42 01/10/2000
Director of Finance/CFO - 01/01/2002
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 42 19/05/2010
Director/Board Member 63 19/05/2010
Director/Board Member 61 12/07/2011
Date Insider Type Main position Quantity % Market Cap.
30/09/20
Donev Investments Ad
BuyCompany 25,489 0.0189%
30/09/20Buy

Chief Executive Officer

12,000 0.0089%
29/09/20
Donev Investments Ad
BuyCompany 9,000 0.0067%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-0.52%+61.79%+111.28% 1.16B
-1.52%+3.09%-19.18%-10.72% 5.92B
-0.27%-2.82%-26.89%-45.29% 3.23B
-4.77%-8.96%-24.01%-42.26% 3.37B
+3.71%-3.98%-38.12%-12.52% 3.26B
+3.54%-0.05%+95.84% - 2.56B
-1.59%-0.67%-19.58%-5.20% 2.48B
-2.91%-5.29%-5.77%-46.32% 2.59B
+2.27%-1.04%+5.81%+42.47% 1.78B
-3.30%-0.68%-27.49%-29.96% 1.57B
Average -0.48%-0.80%+0.24%-4.28% 2.79B
Weighted average by Cap. -0.62%-0.65%-6.60%-14.48%

Financials

2024 2025
Net sales 2.14B 1.29B 1.09B 1.02B 958M 1.77B 122B 1.8B 12.11B 4.7B 58.32B 4.83B 4.72B 203B 2.63B 1.58B 1.35B 1.25B 1.18B 2.18B 150B 2.22B 14.91B 5.78B 71.76B 5.95B 5.81B 250B
Net income 77.85M 46.8M 39.8M 37.06M 34.85M 64.51M 4.43B 65.67M 441M 171M 2.12B 176M 172M 7.39B 134M 80.26M 68.27M 63.57M 59.78M 111M 7.6B 113M 756M 293M 3.64B 302M 295M 12.67B
Net Debt 444M 267M 227M 211M 199M 368M 25.27B 375M 2.52B 976M 12.11B 1B 981M 42.16B 541M 325M 277M 258M 242M 449M 30.8B 457M 3.06B 1.19B 14.75B 1.22B 1.19B 51.37B
Logo Sopharma AD
Sopharma AD, formerly Sopharma AD Sofia, is a Bulgaria-based company engaged in the generic pharmaceutical industry. The Company specializes in the production and trade of medical substances and finished drug forms, as well as research and development in the field of medical products. Through the ampoule plant, tablet plant and the plant in Vrabevo it produces medicines, such as analgesics, antipyretics, cardiovascular medicines as well as drugs for respiratory disease treatment, among others. The Company offers its products under the brand Tribestan, Nivalin and Tabex, among others. In addition, it specializes in the gamma-sterilization of medical materials. It is the parent company of Sopharma Group and operates domestically and abroad in such countries as Russian Federation, Poland, Ukraine, Serbia, the United States and the United Kingdom, among others.
Employees
6,005
Date Price Change Volume
30/06/26 €1.930 -.--% 30,702
29/06/26 €1.930 -.--% 5,711
26/06/26 €1.930 -.--% 16,156
25/06/26 €1.930 -.--% 47,034
24/06/26 €1.930 -0.26% 36,298

Annual profits - Rate of surprise